GT Biopharma, Inc.GTBPNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank71
5Y CAGR-41.4%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-41.4%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 91.54% |
| 2024 | -70.00% |
| 2023 | -15.70% |
| 2022 | -47.97% |
| 2021 | 468.26% |
| 2020 | 1329.55% |
| 2019 | -98.44% |
| 2018 | -90.01% |
| 2017 | 1017372.00% |
| 2016 | -53.70% |